Incident Heart Failure is Common and Underrecognized in Patients with Biopsy-Proven Metabolic Dysfunction-Associated Steatotic Liver Disease
We found a high incidence of HF in patients with biopsy-proven MASLD. Despite nearly half of patients having suspected HF, very few carried a chart diagnosis. Screening for HF in high-risk patients and establishment of formal care pathways to address early HF may reduce morbidity and mortality.
Authors
- Manal F. Abdelmalek (ORCID: https://orcid.org/0000-0002-5001-8618)
- Kara Wegermann (ORCID: https://orcid.org/0000-0002-1024-9040)
- Anna Mae Diehl (ORCID: https://orcid.org/0000-0003-1859-089X)
- Carolyn Ahlers (ORCID: https://orcid.org/0000-0002-8149-1774)
- Fouad Chouairi (ORCID: https://orcid.org/0000-0001-8715-6718)
- Marat Fudim (ORCID: https://orcid.org/0000-0002-8671-7007)
- Georgia Sofia Karachaliou (ORCID: https://orcid.org/0000-0003-4091-3798)
- Tor Biering‐Sørensen (ORCID: https://orcid.org/0000-0003-4209-2778)
- Cynthia A. Moylan (ORCID: https://orcid.org/0000-0001-8454-7086)
- Sandra Au (ORCID: https://orcid.org/0000-0002-7924-3982)
- Kaela Miller
Institutions
- University of Copenhagen (DK)
- Steno Diabetes Centers (DK)
- Gentofte Hospital (DK)
- Clinical Research Institute (US)
- Mayo Clinic in Arizona (US)
- Durham VA Medical Center (US)
- Duke University Health System (US)
Publication Details
- Journal
- European Journal of Heart Failure
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1002/ejhf.3697
- Citations
- 4
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.42
Funders
- American Heart Association